JPMorgan Downgrades Replimune Group (REPL) to Underweight
JPMorgan analyst Anupam Rama downgraded Replimune Group (NASDAQ: REPL) from Neutral to Underweight.The analyst comments: "We are moving to an ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)